Insider · CIK 1193210
Bruce C Cozadd
- Director at Jazz Pharmaceuticals JAZZ: 1 buys, 179 sales
- Director at Cerus CERS: 0 buys, 3 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys1
Open-market sales182
Bought$86K
Sold$98.6M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $215.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 2, 2026. | $1.3M | 339,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 2, 2026. |
| Oct 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $230.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $1.4M | 345,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Sep 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $250.13 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. | $1.5M | 351,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. |
| Aug 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $252.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Aug 3, 2026. | $1.5M | 360,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Aug 3, 2026. |
| Jul 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $240.47 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. | $1.4M | 366,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. |
| Jun 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $235.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $1.4M | 372,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| May 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $203.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2026. | $1.2M | 378,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,684 sh at $190.22 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $701K | 386,998 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,292 sh at $190.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $438K | 384,706 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 24 sh at $191.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $5K | 384,682 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,159 sh at $186.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $588K | 408,637 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,608 sh at $186.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $487K | 406,029 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 233 sh at $187.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $44K | 405,796 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 30,487 sh at $178.06 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $5.4M | 440,345 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 8,380 sh at $179.23 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $1.5M | 431,965 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 507 sh at $179.79 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $91K | 431,458 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 38,126 sh at $177.27 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $6.8M | 393,332 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 3,384 sh at $180.09 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $609K | 405,442 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 8,382 sh at $180.88 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $1.5M | 397,060 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 5,517 sh at $181.81 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $1M | 391,543 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 717 sh at $182.60 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $131K | 390,826 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Oct 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,500 sh at $140.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 3, 2025. | $490K | 408,826 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 3, 2025. |
| Oct 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $131.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 54 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $264K | 412,326 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 54 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Sep 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $127.23 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $382K | 432,973 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Sep 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $390K | 429,973 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Aug 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $113.21 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. | $113K | 435,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. |
| Jul 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $105.26 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. | $53K | 437,473 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. |
| Jul 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $110.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. | $55K | 436,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. |
| Jun 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $110.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Jun 2, 2025. | $55K | 437,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Jun 2, 2025. |
| Jun 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $107.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 2, 2025. | $54K | 438,473 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 2, 2025. |
| May 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $120.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 11 days after the company's 8-K filed Apr 21, 2025. | $60K | 438,807 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 11 days after the company's 8-K filed Apr 21, 2025. |
| May 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $116.35 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 10 days after the company's 8-K filed Apr 21, 2025. | $116K | 439,307 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 10 days after the company's 8-K filed Apr 21, 2025. |
| Apr 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $123.75 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 27 days after the company's 8-K/A filed Mar 5, 2025. | $186K | 440,307 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 27 days after the company's 8-K/A filed Mar 5, 2025. |
| Mar 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,500 sh at $144.25 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 10-K filed Feb 26, 2025. | $938K | 464,058 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 10-K filed Feb 26, 2025. |
| Feb 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $122.31 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Jan 13, 2025. | $183K | 439,744 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Jan 13, 2025. |
| Jan 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $123.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 37 days after the company's 8-K filed Nov 26, 2024. | $185K | 425,525 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 37 days after the company's 8-K filed Nov 26, 2024. |
| Dec 2, 2024 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $121.17 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Nov 26, 2024. | $242K | 427,025 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Nov 26, 2024. |
| Nov 1, 2024 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $110.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 56 days after the company's 8-K filed Sep 6, 2024. | $111K | 428,976 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 56 days after the company's 8-K filed Sep 6, 2024. |
| Feb 1, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $155.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $156K | 367,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 3, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $159.59 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $160K | 370,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 3, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $320K | 368,078 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $157.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $157K | 371,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 10, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $300K | 372,028 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 13,791 sh at $134.02 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.8M | 405,422 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 23,646 sh at $135.18 The filing does not mark this sale as under a Rule 10b5-1 plan. | $3.2M | 381,776 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 7,748 sh at $135.80 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.1M | 374,028 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $155.10 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $155K | 353,311 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 4,517 sh at $152.41 The filing does not mark this sale as under a Rule 10b5-1 plan. | $688K | 358,494 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,170 sh at $153.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $179K | 357,324 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 474 sh at $154.31 The filing does not mark this sale as under a Rule 10b5-1 plan. | $73K | 356,850 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 542 sh at $155.22 The filing does not mark this sale as under a Rule 10b5-1 plan. | $84K | 356,308 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,600 sh at $153.48 The filing does not mark this sale as under a Rule 10b5-1 plan. | $399K | 359,012 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,601 sh at $154.50 The filing does not mark this sale as under a Rule 10b5-1 plan. | $402K | 356,411 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,100 sh at $155.27 The filing does not mark this sale as under a Rule 10b5-1 plan. | $171K | 355,311 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $154.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $155K | 354,311 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold 5,839 sh at $156.65 The filing does not mark this sale as under a Rule 10b5-1 plan. | $915K | 354,848 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold 436 sh at $157.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $69K | 354,412 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $156.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $157K | 353,412 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $240K | 351,912 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 350,987 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,412 sh at $145.42 The filing does not mark this sale as under a Rule 10b5-1 plan. | $351K | 355,937 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,360 sh at $146.05 The filing does not mark this sale as under a Rule 10b5-1 plan. | $199K | 354,577 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,270 sh at $148.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $188K | 353,307 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 831 sh at $148.82 The filing does not mark this sale as under a Rule 10b5-1 plan. | $124K | 352,476 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 489 sh at $149.68 The filing does not mark this sale as under a Rule 10b5-1 plan. | $73K | 351,987 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,600 sh at $155.34 The filing does not mark this sale as under a Rule 10b5-1 plan. | $249K | 354,162 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,177 sh at $156.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $496K | 350,985 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 767 sh at $156.97 The filing does not mark this sale as under a Rule 10b5-1 plan. | $120K | 350,218 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 716 sh at $158.53 The filing does not mark this sale as under a Rule 10b5-1 plan. | $114K | 349,502 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $158.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $159K | 348,502 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,750 sh at $156.33 The filing does not mark this sale as under a Rule 10b5-1 plan. | $274K | 355,084 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,228 sh at $157.49 The filing does not mark this sale as under a Rule 10b5-1 plan. | $508K | 351,856 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,294 sh at $158.37 The filing does not mark this sale as under a Rule 10b5-1 plan. | $205K | 350,562 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $158.64 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $159K | 349,562 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,500 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $560K | 346,062 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $900K | 322,987 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,260 sh at $135.73 The filing does not mark this sale as under a Rule 10b5-1 plan. | $442K | 332,228 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,041 sh at $136.73 The filing does not mark this sale as under a Rule 10b5-1 plan. | $416K | 329,187 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 200 sh at $137.40 The filing does not mark this sale as under a Rule 10b5-1 plan. | $27K | 328,987 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,050 sh at $138.11 The filing does not mark this sale as under a Rule 10b5-1 plan. | $283K | 330,110 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,136 sh at $139.24 The filing does not mark this sale as under a Rule 10b5-1 plan. | $297K | 327,974 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,186 sh at $140.26 The filing does not mark this sale as under a Rule 10b5-1 plan. | $307K | 325,788 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,819 sh at $126.72 The filing does not mark this sale as under a Rule 10b5-1 plan. | $231K | 326,432 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,181 sh at $127.58 The filing does not mark this sale as under a Rule 10b5-1 plan. | $151K | 325,251 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,651 sh at $128.67 The filing does not mark this sale as under a Rule 10b5-1 plan. | $341K | 322,600 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 140 sh at $129.34 The filing does not mark this sale as under a Rule 10b5-1 plan. | $18K | 322,460 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 3,990 sh at $122.38 The filing does not mark this sale as under a Rule 10b5-1 plan. | $488K | 321,309 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 2,758 sh at $123.06 The filing does not mark this sale as under a Rule 10b5-1 plan. | $339K | 318,551 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 1,893 sh at $133.70 The filing does not mark this sale as under a Rule 10b5-1 plan. | $253K | 320,199 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 1,934 sh at $134.78 The filing does not mark this sale as under a Rule 10b5-1 plan. | $261K | 318,265 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 2,729 sh at $135.45 The filing does not mark this sale as under a Rule 10b5-1 plan. | $370K | 315,536 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 4, 2021 | Jazz Pharmaceuticals JAZZ | Sold 6,598 sh at $129.87 The filing does not mark this sale as under a Rule 10b5-1 plan. | $857K | 312,392 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 2, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $169.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $255K | 307,388 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 2, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $43K | 307,138 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 10,850 sh at $180.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $2M | 308,888 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,750 sh at $179.07 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $313K | 319,738 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 5, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $85K | 321,341 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 3, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $164.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $246K | 321,841 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $164.96 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $247K | 323,341 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 9,600 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.6M | 346,357 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 3, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $40K | 318,032 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,250 sh at $156.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $195K | 318,282 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 4, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 7,950 sh at $162.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.3M | 319,532 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $38K | 327,482 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $140.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $141K | 327,732 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $154.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $385K | 328,680 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $145.13 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $145K | 331,180 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,500 sh at $141.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $639K | 332,180 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $134.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $67K | 336,680 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 27, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $390K | 337,180 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $143.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $144K | 298,888 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $149.51 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 300,138 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $38K | 299,888 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 2, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 10,750 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.6M | 301,138 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 5, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $65K | 311,855 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $65K | 312,355 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 3, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $151.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 277,688 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $159.45 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $207K | 278,615 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $167.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $218K | 279,915 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 21, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $164.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $214K | 281,215 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,600 sh at $173.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $278K | 282,515 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 2, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,600 sh at $170.81 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $273K | 284,115 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $510K | 289,715 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $168.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $672K | 285,715 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $151.57 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 292,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 2, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 293,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 9, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 294,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 28, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 262,830 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 12, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $450K | 273,737 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 2, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 276,664 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 12, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $153.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $154K | 277,664 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold 12,073 sh at $153.17 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.8M | 296,418 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold 17,927 sh at $153.68 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2.8M | 278,491 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $152.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 308,491 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 9, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 299,184 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 8, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $126.04 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $315K | 300,066 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 9, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $111.37 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $278K | 281,896 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 12, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $123.81 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $310K | 284,396 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $139.72 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $349K | 286,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $128.53 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $321K | 289,355 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 13, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $131.50 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $329K | 291,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,040 sh at $162.86 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $332K | 294,815 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 460 sh at $164.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $75K | 294,355 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 11, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $177.82 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $445K | 296,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 14, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $177.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $889K | 542,224 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 9, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.16 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $866K | 547,224 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 12, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.85 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $869K | 551,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 14, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $181.45 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $907K | 556,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $170.35 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $852K | 561,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $166.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $835K | 549,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 13, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $161.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $809K | 554,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 9, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $178.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $894K | 559,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 8, 2014 | Cerus CERS | Sold 195 sh at $4.31 The filing does not mark this sale as under a Rule 10b5-1 plan. | $840 | 5,455 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 11, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.63 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $868K | 564,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 14, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $142.77 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $714K | 569,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 9, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $170.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $852K | 574,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 14, 2014 | Cerus CERS | Sold 658 sh at $3.59 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2K | 4,598 −13% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 12, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $133.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $666K | 579,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 8, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $155.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $775K | 597,067 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 10, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $142.34 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $712K | 602,067 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 13, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $128.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $645K | 606,810 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 8, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $123.18 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $616K | 611,810 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 2, 2014 | Cerus CERS | Sold 556 sh at $4.92 The filing does not mark this sale as under a Rule 10b5-1 plan. | $3K | 3,909 −12% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 27, 2014 | Jazz Pharmaceuticals JAZZ | Sold 25,000 sh at $158.36 The filing does not mark this sale as under a Rule 10b5-1 plan. | $4M | 600,754 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 8, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $88.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $354K | 625,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 10, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $87.59 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $438K | 629,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 13, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $81.86 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $409K | 634,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 9, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $73.30 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $367K | 652,691 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 11, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $68.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $342K | 657,691 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 21, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 660,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 14, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $58.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $234K | 661,643 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 3, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 665,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 9, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $54.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $218K | 666,643 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $59.48 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $238K | 623,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 622,161 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 4, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 577,161 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $56.23 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $225K | 578,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 8, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $55.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $222K | 582,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 11, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $50.55 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $202K | 586,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 13, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $51.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $204K | 589,662 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 9, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $56.69 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $227K | 593,662 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 9, 2012 | Jazz Pharmaceuticals JAZZ | Sold 50,000 sh at $49.56 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2.5M | 497,066 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 31, 2010 | Jazz Pharmaceuticals JAZZ | Bought 10,000 sh at $8.60 Their first open-market buy here in SEC Tracker's records. | $86K | 280,181 +4% | Their first open-market buy here in SEC Tracker's records. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.